You are using an older browser version. Please use a supported version for the best MSN experience.

Reliance Pharma Dir Gr

125.81
-1.79
-1.40%
18-08-2017
5 Years
  • Previous Close

    127.59

  • Yield

    0.00%

  • Front load

    0.00

  • Expenses

    1.66%

  • Category

    Sector - Healthcare

  • Morningstar Risk

    -

  • Morningstar Rating -
Profile

Name of Issuer

Reliance Nippon Life Asset Management Ltd.

Fund Style

Open

Fund Manager

Sailesh Raj Bhan

Investment Style

Large Growth

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Purchase Information

Initial Purchase 5,000
Initial Purchase: IRA NA
Initial Purchase: AIP 1,500

Inception

01-01-2013

image beaconimage beaconimage beacon